GT Biopharma, Inc. Share Price
GTBP$0.93
+$0.01 (0.99%) Last updated on 04 Sep, 2025 | 22:49 ISTGT Biopharma, Inc. Stock Performance
Open $0.94 | Prev. Close $0.92 | Circuit Range N/A |
Day Range $0.91 - $0.94 | Year Range $0.90 - $4.10 | Volume 644 |
Average Traded $0.92 |
GT Biopharma, Inc. Share Price Chart
About GT Biopharma, Inc.
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 that targets B7-H3 on the surface of advanced solid tumors; and GTB-7550, a product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.
GT Biopharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
03-Sep-25 | $0.90 | $0.92 | +1.21% |
02-Sep-25 | $0.92 | $0.91 | -1.52% |
29-Aug-25 | $0.95 | $0.92 | -9.95% |
28-Aug-25 | $1.13 | $1.02 | -8.48% |
27-Aug-25 | $1.17 | $1.12 | +0.00% |
26-Aug-25 | $1.13 | $1.12 | +0.90% |
25-Aug-25 | $1.11 | $1.11 | -0.89% |
FAQs on GT Biopharma, Inc. Share Price
Can I buy GT Biopharma, Inc. shares in India?
What is the share price of GT Biopharma, Inc.?
What is the 5 year returns of GT Biopharma, Inc.?
What are the high & low stock price of GT Biopharma, Inc. today?
What is the 52-week high and low of GT Biopharma, Inc. stock?